Sanofi (SNYNF)
OTCMKTS · Delayed Price · Currency is USD
98.12
+0.47 (0.49%)
Aug 14, 2025, 2:21 PM EDT

Sanofi Statistics

Total Valuation

Sanofi has a market cap or net worth of 118.69 billion. The enterprise value is 127.08 billion.

Market Cap118.69B
Enterprise Value 127.08B

Important Dates

The last earnings date was Thursday, July 31, 2025.

Earnings Date Jul 31, 2025
Ex-Dividend Date n/a

Share Statistics

Current Share Class 1.22B
Shares Outstanding n/a
Shares Change (YoY) -0.92%
Shares Change (QoQ) -1.36%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 1.10B

Valuation Ratios

The trailing PE ratio is 11.07 and the forward PE ratio is 10.27.

PE Ratio 11.07
Forward PE 10.27
PS Ratio 2.21
PB Ratio 1.44
P/TBV Ratio 5.83
P/FCF Ratio 10.62
P/OCF Ratio 9.01
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.68, with an EV/FCF ratio of 11.37.

EV / Earnings 11.86
EV / Sales 2.38
EV / EBITDA 8.68
EV / EBIT 11.42
EV / FCF 11.37

Financial Position

The company has a current ratio of 1.27, with a Debt / Equity ratio of 0.32.

Current Ratio 1.27
Quick Ratio 0.81
Debt / Equity 0.32
Debt / EBITDA 1.80
Debt / FCF 2.34
Interest Coverage 16.91

Financial Efficiency

Return on equity (ROE) is 9.00% and return on invested capital (ROIC) is 6.20%.

Return on Equity (ROE) 9.00%
Return on Assets (ROA) 4.60%
Return on Invested Capital (ROIC) 6.20%
Return on Capital Employed (ROCE) 9.78%
Revenue Per Employee 648,117
Profits Per Employee 129,317
Employee Count82,878
Asset Turnover 0.36
Inventory Turnover 1.30

Taxes

In the past 12 months, Sanofi has paid 1.80 billion in taxes.

Income Tax 1.80B
Effective Tax Rate 19.24%

Stock Price Statistics

The stock price has decreased by -6.69% in the last 52 weeks. The beta is 0.41, so Sanofi's price volatility has been lower than the market average.

Beta (5Y) 0.41
52-Week Price Change -6.69%
50-Day Moving Average 96.93
200-Day Moving Average 102.28
Relative Strength Index (RSI) 43.81
Average Volume (20 Days) 105,927

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Sanofi had revenue of 53.71 billion and earned 10.72 billion in profits. Earnings per share was 8.65.

Revenue53.71B
Gross Profit 38.31B
Operating Income 11.02B
Pretax Income 9.38B
Net Income 10.72B
EBITDA 14.19B
EBIT 11.02B
Earnings Per Share (EPS) 8.65
Full Income Statement

Balance Sheet

The company has 18.04 billion in cash and 26.17 billion in debt, giving a net cash position of -8.13 billion.

Cash & Cash Equivalents 18.04B
Total Debt 26.17B
Net Cash -8.13B
Net Cash Per Share n/a
Equity (Book Value) 82.54B
Book Value Per Share 67.55
Working Capital 9.35B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 13.17 billion and capital expenditures -1.99 billion, giving a free cash flow of 11.18 billion.

Operating Cash Flow 13.17B
Capital Expenditures -1.99B
Free Cash Flow 11.18B
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 71.32%, with operating and profit margins of 20.51% and 19.95%.

Gross Margin 71.32%
Operating Margin 20.51%
Pretax Margin 17.46%
Profit Margin 19.95%
EBITDA Margin 26.42%
EBIT Margin 20.51%
FCF Margin 20.81%

Dividends & Yields

Sanofi does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio 52.29%
Buyback Yield 0.92%
Shareholder Yield n/a
Earnings Yield 9.03%
FCF Yield 9.42%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 7